Global Xerostomia (Dry Mouth) Therapeutics Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Xerostomia (Dry Mouth) Therapeutics Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Xerostomia (Dry Mouth) Therapeutics by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Xerostomia (Dry Mouth) Therapeutics by Country/Region, 2017, 2022 & 2028

2.2 Xerostomia (Dry Mouth) Therapeutics Segment by Type

2.2.1 Salivary Stimulants

2.2.2 Salivary Substitutes

2.2.3 Dentifrices

2.3 Xerostomia (Dry Mouth) Therapeutics Sales by Type

2.3.1 Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Type (2017-2022)

2.3.2 Global Xerostomia (Dry Mouth) Therapeutics Revenue and Market Share by Type (2017-2022)

2.3.3 Global Xerostomia (Dry Mouth) Therapeutics Sale Price by Type (2017-2022)

2.4 Xerostomia (Dry Mouth) Therapeutics Segment by Application

2.4.1 OTC

2.4.2 Prescription

2.5 Xerostomia (Dry Mouth) Therapeutics Sales by Application

2.5.1 Global Xerostomia (Dry Mouth) Therapeutics Sale Market Share by Application (2017-2022)

2.5.2 Global Xerostomia (Dry Mouth) Therapeutics Revenue and Market Share by Application (2017-2022)

2.5.3 Global Xerostomia (Dry Mouth) Therapeutics Sale Price by Application (2017-2022)

3 Global Xerostomia (Dry Mouth) Therapeutics by Company

3.1 Global Xerostomia (Dry Mouth) Therapeutics Breakdown Data by Company

3.1.1 Global Xerostomia (Dry Mouth) Therapeutics Annual Sales by Company (2020-2022)

3.1.2 Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Company (2020-2022)

3.2 Global Xerostomia (Dry Mouth) Therapeutics Annual Revenue by Company (2020-2022)

3.2.1 Global Xerostomia (Dry Mouth) Therapeutics Revenue by Company (2020-2022)

3.2.2 Global Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Company (2020-2022)

3.3 Global Xerostomia (Dry Mouth) Therapeutics Sale Price by Company

3.4 Key Manufacturers Xerostomia (Dry Mouth) Therapeutics Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Xerostomia (Dry Mouth) Therapeutics Product Location Distribution

3.4.2 Players Xerostomia (Dry Mouth) Therapeutics Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Xerostomia (Dry Mouth) Therapeutics by Geographic Region

4.1 World Historic Xerostomia (Dry Mouth) Therapeutics Market Size by Geographic Region (2017-2022)

4.1.1 Global Xerostomia (Dry Mouth) Therapeutics Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Xerostomia (Dry Mouth) Therapeutics Annual Revenue by Geographic Region

4.2 World Historic Xerostomia (Dry Mouth) Therapeutics Market Size by Country/Region (2017-2022)

4.2.1 Global Xerostomia (Dry Mouth) Therapeutics Annual Sales by Country/Region (2017-2022)

4.2.2 Global Xerostomia (Dry Mouth) Therapeutics Annual Revenue by Country/Region

4.3 Americas Xerostomia (Dry Mouth) Therapeutics Sales Growth

4.4 APAC Xerostomia (Dry Mouth) Therapeutics Sales Growth

4.5 Europe Xerostomia (Dry Mouth) Therapeutics Sales Growth

4.6 Middle East & Africa Xerostomia (Dry Mouth) Therapeutics Sales Growth

5 Americas

5.1 Americas Xerostomia (Dry Mouth) Therapeutics Sales by Country

5.1.1 Americas Xerostomia (Dry Mouth) Therapeutics Sales by Country (2017-2022)

5.1.2 Americas Xerostomia (Dry Mouth) Therapeutics Revenue by Country (2017-2022)

5.2 Americas Xerostomia (Dry Mouth) Therapeutics Sales by Type

5.3 Americas Xerostomia (Dry Mouth) Therapeutics Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Xerostomia (Dry Mouth) Therapeutics Sales by Region

6.1.1 APAC Xerostomia (Dry Mouth) Therapeutics Sales by Region (2017-2022)

6.1.2 APAC Xerostomia (Dry Mouth) Therapeutics Revenue by Region (2017-2022)

6.2 APAC Xerostomia (Dry Mouth) Therapeutics Sales by Type

6.3 APAC Xerostomia (Dry Mouth) Therapeutics Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Xerostomia (Dry Mouth) Therapeutics by Country

7.1.1 Europe Xerostomia (Dry Mouth) Therapeutics Sales by Country (2017-2022)

7.1.2 Europe Xerostomia (Dry Mouth) Therapeutics Revenue by Country (2017-2022)

7.2 Europe Xerostomia (Dry Mouth) Therapeutics Sales by Type

7.3 Europe Xerostomia (Dry Mouth) Therapeutics Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Xerostomia (Dry Mouth) Therapeutics by Country

8.1.1 Middle East & Africa Xerostomia (Dry Mouth) Therapeutics Sales by Country (2017-2022)

8.1.2 Middle East & Africa Xerostomia (Dry Mouth) Therapeutics Revenue by Country (2017-2022)

8.2 Middle East & Africa Xerostomia (Dry Mouth) Therapeutics Sales by Type

8.3 Middle East & Africa Xerostomia (Dry Mouth) Therapeutics Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Xerostomia (Dry Mouth) Therapeutics

10.3 Manufacturing Process Analysis of Xerostomia (Dry Mouth) Therapeutics

10.4 Industry Chain Structure of Xerostomia (Dry Mouth) Therapeutics

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Xerostomia (Dry Mouth) Therapeutics Distributors

11.3 Xerostomia (Dry Mouth) Therapeutics Customer

12 World Forecast Review for Xerostomia (Dry Mouth) Therapeutics by Geographic Region

12.1 Global Xerostomia (Dry Mouth) Therapeutics Market Size Forecast by Region

12.1.1 Global Xerostomia (Dry Mouth) Therapeutics Forecast by Region (2023-2028)

12.1.2 Global Xerostomia (Dry Mouth) Therapeutics Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Xerostomia (Dry Mouth) Therapeutics Forecast by Type

12.7 Global Xerostomia (Dry Mouth) Therapeutics Forecast by Application

13 Key Players Analysis

13.1 GlaxoSmithKline plc

13.1.1 GlaxoSmithKline plc Company Information

13.1.2 GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Product Offered

13.1.3 GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 GlaxoSmithKline plc Main Business Overview

13.1.5 GlaxoSmithKline plc Latest Developments

13.2 Church & Dwight, Inc.

13.2.1 Church & Dwight, Inc. Company Information

13.2.2 Church & Dwight, Inc. Xerostomia (Dry Mouth) Therapeutics Product Offered

13.2.3 Church & Dwight, Inc. Xerostomia (Dry Mouth) Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Church & Dwight, Inc. Main Business Overview

13.2.5 Church & Dwight, Inc. Latest Developments

13.3 Colgate-Palmolive Company

13.3.1 Colgate-Palmolive Company Company Information

13.3.2 Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Product Offered

13.3.3 Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Colgate-Palmolive Company Main Business Overview

13.3.5 Colgate-Palmolive Company Latest Developments

13.4 Hikma Pharmaceuticals PLC

13.4.1 Hikma Pharmaceuticals PLC Company Information

13.4.2 Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Product Offered

13.4.3 Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Hikma Pharmaceuticals PLC Main Business Overview

13.4.5 Hikma Pharmaceuticals PLC Latest Developments

13.5 Pendopharm

13.5.1 Pendopharm Company Information

13.5.2 Pendopharm Xerostomia (Dry Mouth) Therapeutics Product Offered

13.5.3 Pendopharm Xerostomia (Dry Mouth) Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Pendopharm Main Business Overview

13.5.5 Pendopharm Latest Developments

13.6 Sun Pharmaceuticals Industries Ltd.

13.6.1 Sun Pharmaceuticals Industries Ltd. Company Information

13.6.2 Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Product Offered

13.6.3 Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Sun Pharmaceuticals Industries Ltd. Main Business Overview

13.6.5 Sun Pharmaceuticals Industries Ltd. Latest Developments

13.7 Lupin Pharmaceuticals, Inc.

13.7.1 Lupin Pharmaceuticals, Inc. Company Information

13.7.2 Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Product Offered

13.7.3 Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Lupin Pharmaceuticals, Inc. Main Business Overview

13.7.5 Lupin Pharmaceuticals, Inc. Latest Developments

13.8 Pfizer, Inc.

13.8.1 Pfizer, Inc. Company Information

13.8.2 Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Product Offered

13.8.3 Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Pfizer, Inc. Main Business Overview

13.8.5 Pfizer, Inc. Latest Developments

13.9 Parnell Pharmaceuticals, Inc.

13.9.1 Parnell Pharmaceuticals, Inc. Company Information

13.9.2 Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Product Offered

13.9.3 Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Parnell Pharmaceuticals, Inc. Main Business Overview

13.9.5 Parnell Pharmaceuticals, Inc. Latest Developments

13.10 Acacia Pharma

13.10.1 Acacia Pharma Company Information

13.10.2 Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Product Offered

13.10.3 Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Acacia Pharma Main Business Overview

13.10.5 Acacia Pharma Latest Developments

13.11 OraCoat

13.11.1 OraCoat Company Information

13.11.2 OraCoat Xerostomia (Dry Mouth) Therapeutics Product Offered

13.11.3 OraCoat Xerostomia (Dry Mouth) Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 OraCoat Main Business Overview

13.11.5 OraCoat Latest Developments

14 Research Findings and Conclusion

Table 1. Xerostomia (Dry Mouth) Therapeutics Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Xerostomia (Dry Mouth) Therapeutics Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Salivary Stimulants

Table 4. Major Players of Salivary Substitutes

Table 5. Major Players of Dentifrices

Table 6. Global Xerostomia (Dry Mouth) Therapeutics Sales by Type (2017-2022) & (K MT)

Table 7. Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Type (2017-2022)

Table 8. Global Xerostomia (Dry Mouth) Therapeutics Revenue by Type (2017-2022) & ($ million)

Table 9. Global Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Type (2017-2022)

Table 10. Global Xerostomia (Dry Mouth) Therapeutics Sale Price by Type (2017-2022) & (USD/MT)

Table 11. Global Xerostomia (Dry Mouth) Therapeutics Sales by Application (2017-2022) & (K MT)

Table 12. Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Application (2017-2022)

Table 13. Global Xerostomia (Dry Mouth) Therapeutics Revenue by Application (2017-2022)

Table 14. Global Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Application (2017-2022)

Table 15. Global Xerostomia (Dry Mouth) Therapeutics Sale Price by Application (2017-2022) & (USD/MT)

Table 16. Global Xerostomia (Dry Mouth) Therapeutics Sales by Company (2020-2022) & (K MT)

Table 17. Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Company (2020-2022)

Table 18. Global Xerostomia (Dry Mouth) Therapeutics Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Company (2020-2022)

Table 20. Global Xerostomia (Dry Mouth) Therapeutics Sale Price by Company (2020-2022) & (USD/MT)

Table 21. Key Manufacturers Xerostomia (Dry Mouth) Therapeutics Producing Area Distribution and Sales Area

Table 22. Players Xerostomia (Dry Mouth) Therapeutics Products Offered

Table 23. Xerostomia (Dry Mouth) Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Xerostomia (Dry Mouth) Therapeutics Sales by Geographic Region (2017-2022) & (K MT)

Table 27. Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share Geographic Region (2017-2022)

Table 28. Global Xerostomia (Dry Mouth) Therapeutics Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Xerostomia (Dry Mouth) Therapeutics Sales by Country/Region (2017-2022) & (K MT)

Table 31. Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Country/Region (2017-2022)

Table 32. Global Xerostomia (Dry Mouth) Therapeutics Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Xerostomia (Dry Mouth) Therapeutics Sales by Country (2017-2022) & (K MT)

Table 35. Americas Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Country (2017-2022)

Table 36. Americas Xerostomia (Dry Mouth) Therapeutics Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Country (2017-2022)

Table 38. Americas Xerostomia (Dry Mouth) Therapeutics Sales by Type (2017-2022) & (K MT)

Table 39. Americas Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Type (2017-2022)

Table 40. Americas Xerostomia (Dry Mouth) Therapeutics Sales by Application (2017-2022) & (K MT)

Table 41. Americas Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Application (2017-2022)

Table 42. APAC Xerostomia (Dry Mouth) Therapeutics Sales by Region (2017-2022) & (K MT)

Table 43. APAC Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Region (2017-2022)

Table 44. APAC Xerostomia (Dry Mouth) Therapeutics Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Region (2017-2022)

Table 46. APAC Xerostomia (Dry Mouth) Therapeutics Sales by Type (2017-2022) & (K MT)

Table 47. APAC Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Type (2017-2022)

Table 48. APAC Xerostomia (Dry Mouth) Therapeutics Sales by Application (2017-2022) & (K MT)

Table 49. APAC Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Application (2017-2022)

Table 50. Europe Xerostomia (Dry Mouth) Therapeutics Sales by Country (2017-2022) & (K MT)

Table 51. Europe Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Country (2017-2022)

Table 52. Europe Xerostomia (Dry Mouth) Therapeutics Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Country (2017-2022)

Table 54. Europe Xerostomia (Dry Mouth) Therapeutics Sales by Type (2017-2022) & (K MT)

Table 55. Europe Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Type (2017-2022)

Table 56. Europe Xerostomia (Dry Mouth) Therapeutics Sales by Application (2017-2022) & (K MT)

Table 57. Europe Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Xerostomia (Dry Mouth) Therapeutics Sales by Country (2017-2022) & (K MT)

Table 59. Middle East & Africa Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Xerostomia (Dry Mouth) Therapeutics Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Xerostomia (Dry Mouth) Therapeutics Sales by Type (2017-2022) & (K MT)

Table 63. Middle East & Africa Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Xerostomia (Dry Mouth) Therapeutics Sales by Application (2017-2022) & (K MT)

Table 65. Middle East & Africa Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Xerostomia (Dry Mouth) Therapeutics

Table 67. Key Market Challenges & Risks of Xerostomia (Dry Mouth) Therapeutics

Table 68. Key Industry Trends of Xerostomia (Dry Mouth) Therapeutics

Table 69. Xerostomia (Dry Mouth) Therapeutics Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Xerostomia (Dry Mouth) Therapeutics Distributors List

Table 72. Xerostomia (Dry Mouth) Therapeutics Customer List

Table 73. Global Xerostomia (Dry Mouth) Therapeutics Sales Forecast by Region (2023-2028) & (K MT)

Table 74. Global Xerostomia (Dry Mouth) Therapeutics Sales Market Forecast by Region

Table 75. Global Xerostomia (Dry Mouth) Therapeutics Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Xerostomia (Dry Mouth) Therapeutics Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Xerostomia (Dry Mouth) Therapeutics Sales Forecast by Country (2023-2028) & (K MT)

Table 78. Americas Xerostomia (Dry Mouth) Therapeutics Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Xerostomia (Dry Mouth) Therapeutics Sales Forecast by Region (2023-2028) & (K MT)

Table 80. APAC Xerostomia (Dry Mouth) Therapeutics Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Xerostomia (Dry Mouth) Therapeutics Sales Forecast by Country (2023-2028) & (K MT)

Table 82. Europe Xerostomia (Dry Mouth) Therapeutics Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Xerostomia (Dry Mouth) Therapeutics Sales Forecast by Country (2023-2028) & (K MT)

Table 84. Middle East & Africa Xerostomia (Dry Mouth) Therapeutics Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Xerostomia (Dry Mouth) Therapeutics Sales Forecast by Type (2023-2028) & (K MT)

Table 86. Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Xerostomia (Dry Mouth) Therapeutics Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Xerostomia (Dry Mouth) Therapeutics Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Xerostomia (Dry Mouth) Therapeutics Sales Forecast by Application (2023-2028) & (K MT)

Table 90. Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Xerostomia (Dry Mouth) Therapeutics Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Xerostomia (Dry Mouth) Therapeutics Revenue Market Share Forecast by Application (2023-2028)

Table 93. GlaxoSmithKline plc Basic Information, Xerostomia (Dry Mouth) Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 94. GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Product Offered

Table 95. GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 96. GlaxoSmithKline plc Main Business

Table 97. GlaxoSmithKline plc Latest Developments

Table 98. Church & Dwight, Inc. Basic Information, Xerostomia (Dry Mouth) Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 99. Church & Dwight, Inc. Xerostomia (Dry Mouth) Therapeutics Product Offered

Table 100. Church & Dwight, Inc. Xerostomia (Dry Mouth) Therapeutics Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 101. Church & Dwight, Inc. Main Business

Table 102. Church & Dwight, Inc. Latest Developments

Table 103. Colgate-Palmolive Company Basic Information, Xerostomia (Dry Mouth) Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 104. Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Product Offered

Table 105. Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 106. Colgate-Palmolive Company Main Business

Table 107. Colgate-Palmolive Company Latest Developments

Table 108. Hikma Pharmaceuticals PLC Basic Information, Xerostomia (Dry Mouth) Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 109. Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Product Offered

Table 110. Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 111. Hikma Pharmaceuticals PLC Main Business

Table 112. Hikma Pharmaceuticals PLC Latest Developments

Table 113. Pendopharm Basic Information, Xerostomia (Dry Mouth) Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 114. Pendopharm Xerostomia (Dry Mouth) Therapeutics Product Offered

Table 115. Pendopharm Xerostomia (Dry Mouth) Therapeutics Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 116. Pendopharm Main Business

Table 117. Pendopharm Latest Developments

Table 118. Sun Pharmaceuticals Industries Ltd. Basic Information, Xerostomia (Dry Mouth) Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 119. Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Product Offered

Table 120. Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 121. Sun Pharmaceuticals Industries Ltd. Main Business

Table 122. Sun Pharmaceuticals Industries Ltd. Latest Developments

Table 123. Lupin Pharmaceuticals, Inc. Basic Information, Xerostomia (Dry Mouth) Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 124. Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Product Offered

Table 125. Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 126. Lupin Pharmaceuticals, Inc. Main Business

Table 127. Lupin Pharmaceuticals, Inc. Latest Developments

Table 128. Pfizer, Inc. Basic Information, Xerostomia (Dry Mouth) Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 129. Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Product Offered

Table 130. Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 131. Pfizer, Inc. Main Business

Table 132. Pfizer, Inc. Latest Developments

Table 133. Parnell Pharmaceuticals, Inc. Basic Information, Xerostomia (Dry Mouth) Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 134. Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Product Offered

Table 135. Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 136. Parnell Pharmaceuticals, Inc. Main Business

Table 137. Parnell Pharmaceuticals, Inc. Latest Developments

Table 138. Acacia Pharma Basic Information, Xerostomia (Dry Mouth) Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 139. Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Product Offered

Table 140. Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 141. Acacia Pharma Main Business

Table 142. Acacia Pharma Latest Developments

Table 143. OraCoat Basic Information, Xerostomia (Dry Mouth) Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 144. OraCoat Xerostomia (Dry Mouth) Therapeutics Product Offered

Table 145. OraCoat Xerostomia (Dry Mouth) Therapeutics Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 146. OraCoat Main Business

Table 147. OraCoat Latest Developments

List of Figures

Figure 1. Picture of Xerostomia (Dry Mouth) Therapeutics

Figure 2. Xerostomia (Dry Mouth) Therapeutics Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Xerostomia (Dry Mouth) Therapeutics Sales Growth Rate 2017-2028 (K MT)

Figure 7. Global Xerostomia (Dry Mouth) Therapeutics Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Xerostomia (Dry Mouth) Therapeutics Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Salivary Stimulants

Figure 10. Product Picture of Salivary Substitutes

Figure 11. Product Picture of Dentifrices

Figure 12. Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Type in 2021

Figure 13. Global Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Type (2017-2022)

Figure 14. Xerostomia (Dry Mouth) Therapeutics Consumed in OTC

Figure 15. Global Xerostomia (Dry Mouth) Therapeutics Market: OTC (2017-2022) & (K MT)

Figure 16. Xerostomia (Dry Mouth) Therapeutics Consumed in Prescription

Figure 17. Global Xerostomia (Dry Mouth) Therapeutics Market: Prescription (2017-2022) & (K MT)

Figure 18. Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Application (2017-2022)

Figure 19. Global Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Application in 2021

Figure 20. Xerostomia (Dry Mouth) Therapeutics Revenue Market by Company in 2021 ($ Million)

Figure 21. Global Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Company in 2021

Figure 22. Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Geographic Region (2017-2022)

Figure 23. Global Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Geographic Region in 2021

Figure 24. Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Region (2017-2022)

Figure 25. Global Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Country/Region in 2021

Figure 26. Americas Xerostomia (Dry Mouth) Therapeutics Sales 2017-2022 (K MT)

Figure 27. Americas Xerostomia (Dry Mouth) Therapeutics Revenue 2017-2022 ($ Millions)

Figure 28. APAC Xerostomia (Dry Mouth) Therapeutics Sales 2017-2022 (K MT)

Figure 29. APAC Xerostomia (Dry Mouth) Therapeutics Revenue 2017-2022 ($ Millions)

Figure 30. Europe Xerostomia (Dry Mouth) Therapeutics Sales 2017-2022 (K MT)

Figure 31. Europe Xerostomia (Dry Mouth) Therapeutics Revenue 2017-2022 ($ Millions)

Figure 32. Middle East & Africa Xerostomia (Dry Mouth) Therapeutics Sales 2017-2022 (K MT)

Figure 33. Middle East & Africa Xerostomia (Dry Mouth) Therapeutics Revenue 2017-2022 ($ Millions)

Figure 34. Americas Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Country in 2021

Figure 35. Americas Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Country in 2021

Figure 36. United States Xerostomia (Dry Mouth) Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 37. Canada Xerostomia (Dry Mouth) Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 38. Mexico Xerostomia (Dry Mouth) Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 39. Brazil Xerostomia (Dry Mouth) Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 40. APAC Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Region in 2021

Figure 41. APAC Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Regions in 2021

Figure 42. China Xerostomia (Dry Mouth) Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 43. Japan Xerostomia (Dry Mouth) Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 44. South Korea Xerostomia (Dry Mouth) Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 45. Southeast Asia Xerostomia (Dry Mouth) Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 46. India Xerostomia (Dry Mouth) Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 47. Australia Xerostomia (Dry Mouth) Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 48. Europe Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Country in 2021

Figure 49. Europe Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Country in 2021

Figure 50. Germany Xerostomia (Dry Mouth) Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 51. France Xerostomia (Dry Mouth) Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 52. UK Xerostomia (Dry Mouth) Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 53. Italy Xerostomia (Dry Mouth) Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 54. Russia Xerostomia (Dry Mouth) Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 55. Middle East & Africa Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Country in 2021

Figure 56. Middle East & Africa Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Country in 2021

Figure 57. Egypt Xerostomia (Dry Mouth) Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 58. South Africa Xerostomia (Dry Mouth) Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 59. Israel Xerostomia (Dry Mouth) Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 60. Turkey Xerostomia (Dry Mouth) Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 61. GCC Country Xerostomia (Dry Mouth) Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 62. Manufacturing Cost Structure Analysis of Xerostomia (Dry Mouth) Therapeutics in 2021

Figure 63. Manufacturing Process Analysis of Xerostomia (Dry Mouth) Therapeutics

Figure 64. Industry Chain Structure of Xerostomia (Dry Mouth) Therapeutics

Figure 65. Channels of Distribution

Figure 66. Distributors Profiles